Abiopharma

🔍 WAN XIN (Executive)

Company: GigaCloud Technology Inc (GCT)

Report Date: 2026-04-10

Detailed Transactions and Holdings:

• Acquired 5,500 shares of Class A Ordinary Shares, par value $0.05 per share (Direct)
  Date: 2026-04-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 15,600.00 | transaction_form_type: 4
• Holds 0 shares of Class A Ordinary Shares, par value $0.05 per share (Direct)
  Date: 2026-04-10 | Code: H | nature_of_ownership: By FAITHFUL WINNER HOLDINGS LIMITED | shares_owned_after: 717,540.00 | Footnotes: F1
• Sold 5,500 shares of Restricted Share Units (Derivative)
  Date: 2026-04-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,600.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4, F4, F5

Footnotes:

• F1: The securities are directly held by FAITHFUL WINNER HOLDINGS LIMITED. Xin Wan is the sole shareholder and sole director of FAITHFUL WINNER HOLDINGS LIMITED and may be deemed to be an indirect beneficial owner of the securities held by FAITHFUL WINNER HOLDINGS LIMITED.
• F2: This report shall not be deemed an admission that any of the reporting persons is the beneficial owner of such securities for purposes of Section 16 of Securities Exchange Act of 1934, as amended, or for any other purpose.
• F3: Each Restricted Share Unit ("RSU") represents a contingent right to receive one share of Class A ordinary shares of the Issuer when vested.
• F4: These RSUs, which were granted on April 10 2025, vest upon the satisfaction of a service condition and have no expiration date. The service condition was fully satisfied on April 10, 2026.
• F5: The RSUs will be vested at the end of the twelve (12)-month period commencing from the date of grant, subject to continuous service. Vested shares will be delivered to the reporting person following vesting.